Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis

Trends Immunol. 2023 Jun;44(6):424-434. doi: 10.1016/j.it.2023.04.001. Epub 2023 Apr 6.

Abstract

The COVID-19 pandemic, caused by SARS-CoV-2, has caused an estimated 5 billion infections and 20 million deaths by respiratory failure. In addition to the respiratory disease, SARS-CoV-2 infection has been associated with many extrapulmonary complications not easily explainable by the respiratory infection. A recent study showed that the SARS-CoV-2 spike protein, which mediates cell entry by binding to the angiotensin-converting enzyme 2 (ACE2) receptor, signals through ACE2 to change host cell behavior. In CD8+ T cells, spike-dependent ACE2-mediated signaling suppresses immunological synapse (IS) formation and impairs their killing ability, leading to immune escape of virus-infected cells. In this opinion article, we discuss the consequences of ACE2 signaling on the immune response and propose that it contributes to the extrapulmonary manifestations of COVID-19.

Keywords: ACE2; COVID-19; SARS-CoV-2; cytotoxic T cell; immunological synapse; spike.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2 / metabolism
  • CD8-Positive T-Lymphocytes / metabolism
  • COVID-19*
  • Humans
  • Immune Evasion
  • Pandemics
  • Protein Binding
  • SARS-CoV-2 / metabolism

Substances

  • Angiotensin-Converting Enzyme 2
  • spike protein, SARS-CoV-2
  • ACE2 protein, human